This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 3

Based on the information you provided, we found the following studies.

  • A Phase 1/2 Study of Nivolumab (IND#124729) in Children, Adolescents, and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab. Study goals: find highest safe dose of nivolumab without causing severe side effects; learn side effects nivolumab causes;learn how your body handles nivolumab;learn the effects of nivolumab on cells and proteins in blood and tumor tissue;see if nivolumab is a beneficial treatment for your tumor. This study is researching all of the following topics: Cancerous bone tumor, Osteosarcoma Hodgkin's lymphoma Melanoma NB, Neuroblastoma Non-Hodgkin's lymphoma Rhabdomyosarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
  • Phase I/II Trial of experimental drug ganetespib in combination with the mTOR inhibitor sirolimus for patients with unresectable or metastatic malignant peripheral nerve sheath tumors (MPNST) Study purpose:find highest safe dose, side effects and any benefits of ganetespib when given with sirolimus; test whether 3D-MRI is better at seeing MPNST than traditional scans This study is researching all of the following topics: Cancerous bone tumor, Osteosarcoma Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old